Press "Enter" to skip to content

New patent expiration for Cubist Pharms drug ENTEREG

2
Listen to this article
Copyright © DrugPatentWatch. Originally published at New patent expiration for Cubist Pharms drug ENTEREG

Annual Drug Patent Expirations for ENTEREG
Annual Drug Patent Expirations for ENTEREG

Entereg is a drug marketed by Cubist Pharms and is included in one NDA. It is available from one supplier. There are four patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for ENTEREG.

This drug has eighteen patent family members in fourteen countries.

The generic ingredient in ENTEREG is alvimopan. One supplier is listed for this compound. Additional details are available on the alvimopan profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Cubist Pharms drug ENTEREG

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!